Category: Technology Licenses
Created On: 2022-04-28
Record Count: 3
- Drug Discovery
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 344566
For the Resulting Intellectual Property, Licensor grants a worldwide, exclusive right and license, with right to sub license (subject, in the case of Products and Theranostic Products, to same sublicensing terms, to use the Resulting IP and Resulting IP Patents for all purposes, including the research, development, manufacture, marketing and sale of Products, Theranostic Products and Diagnostic Products.
For the Vilazodone manufacturing technology Option. Licensor grants an option to obtain a semi-exclusive, paid-up, license under the Vilazodone manufacturing technology, Licensor Patent rights and Know-how to make and have made Vilazodone and Products for so long as Licensee has a license to the Licensor Patents and Know-how.
Product shall mean any product containing Vilazodone as either the single active ingredient or as one of multiple active ingredients.
Theranostic Product shall mean a home-brew test or FDA or EMEA approved kit or device for detecting genetic markers that are correlated to Vilazodone response in humans.
Indications identified with this agreement include
— Depressive Disorder, including but not limited to
Minor Depressive Disorder, Recurrent brief depressive disorder, Major Depressive Disorder, Dysthymic Disorder, Adjustment Disorder With Depressed Mood, Adjustment Disorder With Mixed Anxiety and Depressed Mood, Premenstrual dysphoric disorder, and, Postpsychotic depressive disorder of Schizophrenia.
— Anxiety Disorder, including but not limited to
Panic Disorder, Agoraphobia, Specific Phobia, Social Anxiety Disorder, Obsessive-Compulsive Disorder, Posttraumatic Stress Disorder, Acute Stress Disorder, and,
Generalized Anxiety Disorder.
IPSCIO Record ID: 226310
Licensor hereby grants to Licensee, for the Term, an exclusive license under the Licensor Know-How, to make, use, offer to sell, sell, and import Licensed Products in the Field in the Territory.
Licensor hereby grants to Licensee, for the Term, an exclusive sublicense under the University Know-How, to make, use, offer to sell, sell, and import Licensed Products in the Field in the Territory.
Licensor hereby grants to Licensee, for the Term, a non-exclusive sublicense under the Nanosizing Licensed Patents, solely in conjunction with the licenses granted of this Restated Agreement, to make, use, and sell Licensed Products in the Field in the Territory.
Ganaxolone is a synthetic small molecule made through a series of organic chemistry steps starting with commercially available organic chemical raw materials. Ganaxolone is a high-dose water insoluble compound.
Ganaxolone means 3-alpha-hydroxy-3-beta-methyl 5-alpha-pregnan-20-one.
University Licensed Patents means
U.S. Pat. No. 5,232,917 â€œMethods, Compositions and Compounds for Allosteric Modulation of the GABA receptorâ€;
U.S. Pat. No. 5,591,733 â€œMethods, Compositions and Compounds for Allosteric Modulation of the GABA Receptor by Members of the Androstane and Pregnane Seriesâ€;
U.S. Pat. No. 5,208,227 â€œMethod, Compositions, and Compounds for Modulating Brain Excitabilityâ€;
U.S. Pat. No. 5,319,115 â€œMethod for making 3a-Hydroxy, 3b-Substituted Pregnanesâ€;
Nanosizing Licensed Patents means U.S. Provisional Pat. Application No. 60/172,573, filed December 20, 1999; and all U.S. and foreign Patents that claim priority therefrom.
â€œFieldâ€ means the diagnosis, prevention and treatment of all diseases, disorders or conditions, other than those diseases, disorders or conditions which are in the Excluded Field. Examples of diseases, disorders, or conditions that are within the Field include psychiatric and stress related disorders (e.g., generalized anxiety, obsessive-compulsive disorders, panic disorders, sleep disorders, depression psychoses, schizophrenia, premenstrual dysphoric disorder, posttraumatic stress disorder, and social isolation), addiction (i.e., alcoholism, benzodiazepine abuse, amphetamine abuse, and cocaine abuse), seizure disorders, disorders involving neurodegeneration and neuronal apoptosis where neuronal protection or neurogenesis provides a functional benefit (e.g., Alzheimerâ€™s disease, pre and post-natal treatment for autism, attention deficit disorder, fragile X syndrome), lysosomal storage disorders, and atherosclerosis.
IPSCIO Record ID: 303332